Leslie E. Lehmann , MD
|
Director, Clinical Stem Cell Transplantation Program
Office Phone: 617-632-4882
Appointment Line: 1-888-PEDI-ONC (733-4662)
Fax: 617-632-2095
NPI: 1770542359 |
Departments/Divisions
Specialties
hematology/oncology
hematopoietic stem cell transplantation
hematopoietic stem cell transplantation for sickle cell disease and thalassemia
late effects of transplantation
role of exercise in hematopoietic stem cell transplantation
second transplants
transplant for BM failure syndrome
Services/Programs
Academic Appointments
Assistant Professor of Pediatrics, Harvard Medical School
Certifications
Pediatric Hematology/Oncology, Pediatrics
Medical School
Duke University School of Medicine, Durham, NC
Residency
Pediatrics, Duke University School of Medicine, Durham, NC
Fellowship
Pediatric Hematology/Oncology, Children's Hospital Boston/Dana-Farber Cancer Institute, Boston, MA
Duncan CN, Vrooman L, Apfelbaum EM, Whitley K, Bechard L, Lehmann LE. 25-Hydroxy Vitamin D Deficiency Following Pediatric Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2011 May;17(5):749-53.
Lightdale JR, Randolph AG, Tran CM, Jiang H, Colon A, Houlahan K, Billet A, Sloan S, Lehmann LE. Impact of a Conservative Red Blood Cell Transfusion Strategy in Children Undergoing Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2011, Nov 11. [Epub ahead of print]
Oshrine B, Lehmann LE, Duncan CN. Safety and utility of liver biopsy after pediatric hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2011 Apr;33(3):e92-7
-
Dana-Farber Cancer InstituteDepartment of Pediatric Oncology450 Brookline AveBoston, MA 02215Phone: 617-632-4882Fax: 617-632-2095